Thalia Therapeutics acquires US firm backed by fundraise
Posted:
AIM-listed biotechnology company Thalia Therapeutics has announced the acquisition of US-based oncology firm Sanmirna Therapeutics alongside an oversubscribed £2.75m fundraise.
The MHRA published the findings of the National Commission into the Regulation of AI in Healthcare's Call for Evidence, the most substantial assessment yet of how the UK should regulate AI in health and care. The Commission is the independent advisory group…
Hospices across England are being offered access to a new NHS-backed AI programme designed to give doctors and nurses more time with patients during the final stages of life.
The initiative will provide selected hospices with free access to CLEARnotes,…
Attendees
Sponsors and Exhibitors
Contact us